Pharmacogenetic Landscape of DPYD Variants in South Asian Populations by Integration of Genome-Scale Data

References

• Longley DB , HarkinDP , JohnstonPG . 5-fluorouracil: mechanisms of action and clinical strategies . Nat. Rev. Cancer3 ( 5 ), 330 – 338 ( 2003 ).
   PubMed Web of Science ®Google Scholar
• Malet-Martino M , MartinoR . Oncologist clinical studies of three oral prodrugs of 5-fluorouracil . Oncologist7 ( 4 ), 288 – 323 ( 2002 ).
   PubMed Web of Science ®Google Scholar
• Baerlocher GM , BeerJH , OwenGR , MeiselmanHJ , ReinhartWH . The anti-neoplastic drug 5-fluorouracil produces echinocytosis and affects blood rheology . Br. J. Haematol.99 ( 2 ), 426 – 432 ( 1997 ).
   PubMed Web of Science ®Google Scholar
• Petrelli N , HerreraL , RustumYet al. A prospective randomized trial of 5-fluorouracil versus 5-fluorouracil and high-dose leucovorin versus 5-fluorouracil and methotrexate in previously untreated patients with advanced colorectal carcinoma . J. Clin. Oncol.5 ( 10 ), 1559 – 1565 ( 1987 ).
   PubMed Web of Science ®Google Scholar
• Wadler S , SchwartzEL , GoldmanMet al. Fluorouracil and recombinant alfa-2a-interferon: an active regimen against advanced colorectal carcinoma . J. Clin. Oncol.7 ( 12 ), 1769 – 1775 ( 1989 ).
   PubMed Web of Science ®Google Scholar
• Blanke CD , KasimisB , ScheinP , CapizziR , KurmanM . Phase II study of trimetrexate, fluorouracil, and leucovorin for advanced colorectal cancer . J. Clin. Oncol.15 ( 3 ), 915 – 920 ( 1997 ).
   PubMed Web of Science ®Google Scholar
• Leichman CG , FlemingTR , MuggiaFMet al. Phase II study of fluorouracil and its modulation in advanced colorectal cancer: a Southwest Oncology Group study . J. Clin. Oncol.13 ( 6 ), 1303 – 1311 ( 1995 ).
   PubMed Web of Science ®Google Scholar
• Lokich JJ , AhlgrenJD , GulloJJ , PhilipsJA , FryerJG . A prospective randomized comparison of continuous infusion fluorouracil with a conventional bolus schedule in metastatic colorectal carcinoma: a mid-atlantic oncology program study . J. Clin. Oncol.7 ( 4 ), 425 – 432 ( 1989 ).
   PubMed Web of Science ®Google Scholar
• Poon MA , O’ConnellMJ , WieandHSet al. Biochemical modulation of fluorouracil with leucovorin: confirmatory evidence of improved therapeutic efficacy in advanced colorectal cancer . J. Clin. Oncol.9 ( 11 ), 1967 – 1972 ( 1991 ).
   PubMed Web of Science ®Google Scholar
• Macdonald JS . Toxicity of 5-fluorouracil . Oncology (Williston Park).13 ( 7 Suppl. 3 ), 33 – 34 ( 1999 ).
   PubMed Web of Science ®Google Scholar
• Blasco H , Boisdron-CelleM , BougnouxPet al. A well-tolerated 5-FU-based treatment subsequent to severe capecitabine-induced toxicity in a DPD-deficient patient . Br. J. Clin. Pharmacol.65 ( 6 ), 966 – 970 ( 2008 ).
   PubMed Web of Science ®Google Scholar
• Shahrokni A , RajebiMR , SaifMW . Toxicity and efficacy of 5-fluorouracil and capecitabine in a patient with TYMS gene polymorphism: a challenge or a dilemma?Clin. Colorectal Cancer8 ( 4 ), 231 – 234 ( 2009 ).
   PubMed Web of Science ®Google Scholar
• Scartozzi M , MaccaroniE , GiampieriRet al. 5-Fluorouracil pharmacogenomics: still rocking after all these years? Pharmacogenomics 12 ( 2 ), 251 – 265 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• Petak I , TillmanDM , HoughtonJA , LinesC . p53 dependence of Fas induction and acute apoptosis in response to 5-fluorouracil-leucovorin in human colon carcinoma cell lines p53 dependence of Fas induction and acute apoptosis in response to 5-fluorouracil-leucovorin in human colon . Carcinoma6 , 4432 – 4441 ( 2000 ).
   Google Scholar
• Ajani J . Review of capecitabine as oral treatment of gastric, gastroesophageal and esophageal cancers . Cancer107 ( 2 ), 221 – 231 ( 2006 ).
   PubMed Web of Science ®Google Scholar
• Milano G , McLeodHL . Can dihydropyrimidine dehydrogenase impact 5-fluorouracil-based treatment?Eur. J. Cancer36 ( 1 ), 37 – 42 ( 2000 ).
   PubMed Web of Science ®Google Scholar
• Anan K , MitsuyamaS , TamaeKet al. Increased dihydropyrimidine dehydrogenase activity in breast cancer . J. Surg. Oncol.82 ( 3 ), 174 – 179 ( 2003 ).
   PubMed Web of Science ®Google Scholar
• Takai S , Fernandez-SalgueroP , KimuraS , GonzalezFJ , YamadaK . Assignment of the human dihydropyrimidine dehydrogenase gene (DPYD) to chromosome region 1p22 by fluorescence in situ hybridization . Genomics24 ( 3 ), 613 – 614 ( 1994 ).
   PubMed Web of Science ®Google Scholar
• Wei X , McLeodHL , McMurroughJ , GonzalezFJ , Fernandez-SalgueroP . Molecular basis of the human dihydropyrimidine dehydrogenase deficiency and 5-fluorouracil toxicity . J. Clin. Invest.98 ( 3 ), 610 – 615 ( 1996 ).
   PubMed Web of Science ®Google Scholar
• Offer SM , WegnerNJ , FossumC , WangK , DiasioRB . Phenotypic profiling of DPYD variations relevant to 5-fluorouracil sensitivity using real-time cellular analysis and in vitro measurement of enzyme activity . Cancer Res.73 ( 6 ), 1958 – 1968 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Lu Z , ZhangR , DiasioRBR . Dihydropyrimidine dehydrogenase activity in human peripheral blood mononuclear cells and liver: population characteristics, newly identified deficient patients, and clinical implication in 5-fluorouracil chemotherapy . Cancer Res.53 ( 22 ), 5433 – 5438 ( 1993 ).
   PubMed Web of Science ®Google Scholar
• Milano G , EtienneMC , PierrefiteV , Barberi-HeyobM , Deporte-FetyR , RenéeN . Dihydropyrimidine dehydrogenase deficiency and fluorouracil-related toxicity . Br. J. Cancer79 ( 3–4 ), 627 – 630 ( 1999 ).
   PubMed Web of Science ®Google Scholar
• Milano G , EtienneMC . Dihydropyrimidine dehydrogenase (DPD) and clinical pharmacology of 5-fluorouracil (review) . Anticancer Res.14 ( 6A ), 2295 – 2297 ( 1994 ).
   PubMed Web of Science ®Google Scholar
• Lunenburg CATC , HenricksLM , GuchelaarHet al. Sciencedirect prospective DPYD genotyping to reduce the risk of fluoropyrimidine-induced severe toxicity: ready for prime time . Eur. J. Cancer54 , 40 – 48 ( 2016 ).
   PubMed Web of Science ®Google Scholar
• Amstutz U , FroehlichTK , LargiadèrCR . Dihydropyrimidine dehydrogenase gene as a major predictor of severe 5-fluorouracil toxicity . Pharmacogenomics12 ( 9 ), 1321 – 1336 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• Steiner M , SeuleM , SteinerBet al. 5-Fluorouracil/irinotecan induced lethal toxicity as a result of a combined pharmacogenetic syndrome: report of a case . J. Clin. Pathol.58 ( 5 ), 553 – 555 ( 2005 ).
   PubMed Web of Science ®Google Scholar
• Moore AY . Clinical applications for topical 5-fluorouracil in the treatment of dermatological disorders . J. Dermatolog. Treat.20 ( 6 ), 328 – 335 ( 2009 ).
   PubMed Web of Science ®Google Scholar
• Shah VV , AldahanAS , MlackerS , AlsaidanM , SamarkandyS , NouriK . 5-fluorouracil in the treatment of keloids and hypertrophic scars: a comprehensive review of the literature . Dermatol. Ther. (Heidelb.)6 ( 2 ), 169 – 183 ( 2016 ).
   PubMed Web of Science ®Google Scholar
• Stough DOW , BuckoAD , VamvakiasG , RafalES , DavisSA . Fluorouracil cream 0.5% for the treatment of actinic keratoses on the face interim results of an 18-month open-label study . J. Clin. Aesthet. Dermatol.1 ( 2 ), 16 – 21 ( 2008 ).
   PubMedGoogle Scholar
• Werschler P . Considerations for use of fluorouracil cream 0.5% for the treatment of actinic keratosis in elderly patients . J. Clin. Aesthet. Dermatol.1 ( 2 ), 22 – 27 ( 2008 ).
   PubMedGoogle Scholar
• Iyer SN , TilakAV , MukherjeeMS , SinghalRS . Genotype frequencies of drug-metabolizing enzymes responsible for purine and pyrimidine antagonists in a healthy Asian-Indian population . Biochem. Genet.50 ( 9–10 ), 684 – 693 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Saif MW , EzzeldinH , VanceK , SellersS , DiasioRB . DPYD*2A mutation: the most common mutation associated with DPD deficiency . Cancer Chemother. Pharmacol.60 ( 4 ), 503 – 507 ( 2007 ).
   PubMed Web of Science ®Google Scholar
• Iyer SN , SinghalRS , HegdeMR , AnkalaA . Genetic variation in dihydropyrimidine dehydrogenase (DPYD) gene in a healthy adult Indian population . Ann. Hum. Biol.42 ( 1 ), 97 – 100 ( 2015 ).
   PubMed Web of Science ®Google Scholar
• Auton A , AbecasisGR , AltshulerDMet al. A global reference for human genetic variation . Nature526 ( 7571 ), 68 – 74 ( 2015 ).
   PubMed Web of Science ®Google Scholar
• INdian DIabetes COnsortium . INDICO: The development of a resource for epigenomic study of Indians undergoing socioeconomic transition . Hugo J.5 ( 1–4 ), 65 – 69 ( 2011 ).
   PubMedGoogle Scholar
• Wong L-P , OngRT-H , PohW-Tet al. Deep whole-genome sequencing of 100 southeast Asian Malays . Am. J. Hum. Genet.92 ( 1 ), 52 – 66 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Chambers JC , AbbottJ , ZhangWet al. The south Asian genome . PLoS ONE9 ( 8 ), e102645 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• Wong L-P , LaiJK-H , SawW-Yet al. Insights into the genetic structure and diversity of 38 south Asian Indians from deep whole-genome sequencing . PLoS Genet.10 ( 5 ), e1004377 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• Mondal M , CasalsF , XuTet al. Genomic analysis of Andamanese provides insights into ancient human migration into Asia and adaptation . Nat. Genet.48 ( 9 ), 1066 – 1070 ( 2016 ).
   PubMed Web of Science ®Google Scholar
• Tabassum R , ChauhanG , DwivediOPet al. Genome-wide association study for Type 2 diabetes in indians identifies a new susceptibility locus at 2q21 . Diabetes62 ( 3 ), 977 – 986 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Exome Aggregation Consortium ; LekM , KarczewskiKJet al.Analysis of protein-coding genetic variation in 60,706 humans . Nature536 ( 7616 ), 285 – 291 ( 2016 ).
   PubMed Web of Science ®Google Scholar
• The International HapMap Project . Nature426 ( 6968 ), 789 – 796 ( 2003 ).
   PubMed Web of Science ®Google Scholar
• Sim N-L , KumarP , HuJ , HenikoffS , SchneiderG , NgPC . SIFT webserver: predicting effects of amino acid substitutions on proteins . Nucleic Acids Res.40 , W452 – W457 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Adzhubei IA , SchmidtS , PeshkinLet al. A method and server for predicting damaging missense mutations . Nat. Methods7 ( 4 ), 248 – 249 ( 2010 ).
   PubMed Web of Science ®Google Scholar
• Choi Y , ChanAP . PROVEAN web server: a tool to predict the functional effect of amino acid substitutions and indels . Bioinformatics31 ( 16 ), 2745 – 2747 ( 2015 ).
   PubMed Web of Science ®Google Scholar
• Whirl-Carrillo M , McDonaghEM , HebertJMet al. Pharmacogenomics knowledge for personalized medicine . Clin. Pharmacol. Ther.92 ( 4 ), 414 – 417 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Hunter JD . Matplotlib: A 2D graphics environment . Comput. Sci. Eng.9 ( 3 ), 99 – 104 ( 2007 ).
   Web of Science ®Google Scholar
• Burland TG . DNASTAR’s lasergene sequence analysis software . Methods Mol. Biol.132 , 71 – 91 ( 2000 ).
   PubMedGoogle Scholar
• Miura K , KinouchiM , IshidaKet al. 5-FU metabolism in cancer and orally-administrable 5-FU drugs . Cancers (Basel)2 ( 3 ), 1717 – 1730 ( 2010 ).
   PubMedGoogle Scholar
• Zhang X , DiasioRB . Regulation of human dihydropyrimidine dehydrogenase: implications in the pharmacogenetics of 5-FU-based chemotherapy . Pharmacogenomics8 ( 3 ), 257 – 265 ( 2007 ).
   PubMed Web of Science ®Google Scholar
• Vinod BS , AntonyJ , NairHHet al. Mechanistic evaluation of the signaling events regulating curcumin-mediated chemosensitization of breast cancer cells to 5-fluorouracil . Cell Death Dis.4 , e505 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Deenen MJ , MeulendijksD , CatsAet al. Upfront genotyping of DPYD*2A to individualize fluoropyrimidine therapy: a safety and cost analysis . J. Clin. Oncol.34 ( 3 ), 227 – 234 ( 2016 ).
   PubMed Web of Science ®Google Scholar
• Baek JH , KimJG , KimSNet al. Unpredicted severe toxicity after 5-fluorouracil treatment due to dihydropyrimidine dehydrogenase deficiency . Korean J. Intern. Med.21 ( 1 ), 43 – 45 ( 2006 ).
   PubMedGoogle Scholar
• Saif MW . Dihydropyrimidine dehydrogenase gene (DPYD) polymorphism among Caucasian and non-Caucasian patients with 5-FU- and capecitabine-related toxicity using full sequencing of DPYD . Cancer Genomics Proteomics10 ( 2 ), 89 – 92 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Lee AM , ShiQ , PaveyEet al. DPYD variants as predictors of 5-fluorouracil toxicity in adjuvant colon cancer treatment (NCCTG N0147) . J. Natl Cancer Inst.106 ( 12 ), 1 – 12 ( 2014 ).
   Google Scholar
• Giri AK , KhanNM , BasuA , TandonN , ScariaV , BharadwajD . Pharmacogenetic landscape of clopidogrel in north Indians suggest distinct interpopulation differences in allele frequencies . Pharmacogenomics15 ( 5 ), 643 – 653 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• Caudle KE , ThornCF , KleinTEet al. Clinical Pharmacogenetics Implementation Consortium guidelines for dihydropyrimidine dehydrogenase genotype and fluoropyrimidine dosing . Clin. Pharmacol. Ther.94 ( 6 ), 640 – 645 ( 2013 ).
   PubMed Web of Science ®Google Scholar